| Tbio | Osteomodulin |
May be implicated in biomineralization processes. Has a function in binding of osteoblasts via the alpha(V)beta(3)-integrin (By similarity).
Comments
| Disease | Target Count | P-value |
|---|---|---|
| ovarian cancer | 8520 | 3.0e-11 |
| adrenocortical carcinoma | 1428 | 4.5e-11 |
| lung carcinoma | 2843 | 1.6e-10 |
| Atopic dermatitis | 952 | 1.1e-05 |
| invasive ductal carcinoma | 2951 | 1.0e-03 |
| psoriasis | 6694 | 1.1e-03 |
| oligodendroglioma | 2850 | 1.4e-03 |
| pituitary cancer | 1972 | 2.0e-03 |
| ependymoma | 4679 | 2.5e-03 |
| intraductal papillary-mucinous carcinoma (IPMC) | 2989 | 2.8e-03 |
| ductal carcinoma in situ | 1745 | 4.0e-03 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 4.2e-03 |
| sonic hedgehog group medulloblastoma | 467 | 5.6e-03 |
| astrocytic glioma | 2597 | 1.8e-02 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 2.8e-02 |
| interstitial cystitis | 2312 | 2.8e-02 |
| cutaneous lupus erythematosus | 1057 | 3.2e-02 |
| non diabetic and post-ischemic heart failure | 200 | 3.6e-02 |
| Breast cancer | 3578 | 3.7e-02 |
| Disease | log2 FC | p |
|---|---|---|
| adrenocortical carcinoma | -2.114 | 4.5e-11 |
| astrocytic glioma | -1.100 | 1.8e-02 |
| Atopic dermatitis | -2.800 | 1.1e-05 |
| Breast cancer | 2.300 | 3.7e-02 |
| cutaneous lupus erythematosus | -1.400 | 3.2e-02 |
| ductal carcinoma in situ | -1.600 | 4.0e-03 |
| ependymoma | -1.700 | 2.5e-03 |
| interstitial cystitis | -1.500 | 2.8e-02 |
| intraductal papillary-mucinous adenoma (... | -2.200 | 4.2e-03 |
| intraductal papillary-mucinous carcinoma... | -2.400 | 2.8e-03 |
| intraductal papillary-mucinous neoplasm ... | -2.300 | 2.8e-02 |
| invasive ductal carcinoma | -2.200 | 1.0e-03 |
| lung carcinoma | -2.100 | 1.6e-10 |
| non diabetic and post-ischemic heart fai... | 1.400 | 3.6e-02 |
| oligodendroglioma | -1.700 | 1.4e-03 |
| ovarian cancer | -2.700 | 3.0e-11 |
| pituitary cancer | -1.100 | 2.0e-03 |
| psoriasis | -1.300 | 1.1e-03 |
| sonic hedgehog group medulloblastoma | 1.400 | 5.6e-03 |
MGFLSPIYVIFFFFGVKVHCQYETYQWDEDYDQEPDDDYQTGFPFRQNVDYGVPFHQYTLGCVSECFCPT 1 - 70 NFPSSMYCDNRKLKTIPNIPMHIQQLYLQFNEIEAVTANSFINATHLKEINLSHNKIKSQKIDYGVFAKL 71 - 140 PNLLQLHLEHNNLEEFPFPLPKSLERLLLGYNEISKLQTNAMDGLVNLTMLDLCYNYLHDSLLKDKIFAK 141 - 210 MEKLMQLNLCSNRLESMPPGLPSSLMYLSLENNSISSIPEKYFDKLPKLHTLRMSHNKLQDIPYNIFNLP 211 - 280 NIVELSVGHNKLKQAFYIPRNLEHLYLQNNEIEKMNLTVMCPSIDPLHYHHLTYIRVDQNKLKEPISSYI 281 - 350 FFCFPHIHTIYYGEQRSTNGQTIQLKTQVFRRFPDDDDESEDHDDPDNAHESPEQEGAEGHFDLHYYENQ 351 - 420 E//
